TY  - RPRT
TI  - High-integrity nanoemulsions formulation of resiquimod (R848) enhances stability and delivery for triple negative breast cancer immunotherapy
AU  - Salem, A.
AU  - Attia, S.
AU  - El-Ghlban, S.
AU  - Montaser, A. S.
AU  - Abdelhameed, M. F.
AU  - Helmy, M. W.
AU  - Attia, M. F.
PY  - 2025
DO  - 10.1101/2025.04.04.647265
UR  - https://www.biorxiv.org/content/10.1101/2025.04.04.647265v1
ID  - 10.1101/2025.04.04.647265
ER  -